Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tenet Healthcare Corporation (THC) vs State Street Technology Select Sector SPDR ETF (XLK) Price & Performance

Tenet Healthcare CorporationTrade
State Street Technology Select Sector SPDR ETFTrade

Price performance (Past 24H)

Key statistics

Tenet Healthcare Corporation vs State Street Technology Select Sector SPDR ETF — how do they compare? Tenet Healthcare Corporation trades at $261.33 (market cap $20.98B), while State Street Technology Select Sector SPDR ETF trades at $198.45 (market cap $132.55B). The key difference: State Street Technology Select Sector SPDR ETF is far larger — about 6.3× Tenet Healthcare Corporation's market cap, and State Street Technology Select Sector SPDR ETF is trading nearer its 52-week high, Tenet Healthcare Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and State Street Technology Select Sector SPDR ETF for 49 Days on average.

THCXLK
Market Cap
$20.98B$132.55B
Volume
428,0089,063,135
Sector
HealthSector/Thematic
52-Week High
$280.77$202.00
52-Week Low
$161.37$127.49
Typical Hold Time
15 Days49 Days
Enterprise Value
$32.06B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $261.07, up 0.48% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with 82.83% gross margins and consistent earnings beats, while trading at attractive valuations including a 10.07 P/E ratio. Recent news highlights upcoming Q3 2026 earnings on October 29th and positive coverage of the company's growth prospects despite surgical volume challenges.

THC presents a compelling investment case with strong analyst support (81% buy ratings) and a $283.36 consensus target offering 8.5% upside. The healthcare provider shows improving profitability with net margins expected to reach 9.89% in 2026. Key risks include capital allocation sustainability and potential volatility around upcoming earnings, but the combination of value pricing and growth momentum supports a positive outlook.

State Street Technology Select Sector SPDR ETF

XLK, the Technology Select Sector SPDR ETF, trades at $197.73, down 1.82% amid broader tech pressure. The technical outlook is bullish based on moving averages, with support at $196 and resistance at $201. Recent news highlights concentration risks in semiconductor holdings and competition from thematic AI ETFs.

The ETF faces headwinds from potential Fed rate hikes and sector rotation but benefits from strong AI investment themes. Risks include overconcentration in mega-cap tech and interest rate sensitivity, while its low expense ratio and diversified tech exposure offer a defensive growth play.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

THC

No sentiment data available yet.

XLK
54% Buy46% Sell
Avg holding period · 49 Days

Top news

Latest headlines on both assets

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →

About State Street Technology Select Sector SPDR ETF

XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.

Read more on XLK →